help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johannsson, G.
Right arrow Articles by Bengtsson, B.-A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johannsson, G.
Right arrow Articles by Bengtsson, B.-A.
The Journal of Clinical Endocrinology & Metabolism Vol. 82, No. 9 2877-2884
Copyright © 1997 by The Endocrine Society


Original Studies

Two Years of Growth Hormone (GH) Treatment Increase Isometric and Isokinetic Muscle Strength in GH-Deficient Adults1

Gudmundur Johannsson, Gunnar Grimby, Katharina Stibrant Sunnerhagen and Bengt-Åke Bengtsson

Research Center for Endocrinology and Metabolism (G.J., B.Å-B.) and the Department of Rehabilitation Medicine (G.G., K.S.S.), Sahlgrenska University Hospital, Goteborg, Sweden

Address all correspondence and requests for reprints to: Gudmundur Johannsson, M.D., Ph.D., Research Center for Endocrinology and Metabolism, Sahlgrenska University Hospital, S-413 45 Goteborg, Sweden. E-mail: Gudmundur.Johannsson{at}ss.gu.se

GH deficiency in adults is associated with reduced muscle mass and muscle strength. The objective of this trial was to follow the effect of 2 yr of GH treatment in GH-deficient adults on muscle performance in relation to a reference population. Knee extensor and flexor strengths for isometric and isokinetic concentric muscle strength were measured using a Kin-Com dynamometer. Hand-grip strength was measured in both hands. The fatigue index was calculated as the percent reduction in peak torque at 50 repeated isokinetic knee extensions. Superimposed, single twitch electrical stimulation was performed. The GH-deficient subjects had lower isometric knee extensor, knee flexor, and hand-grip strength than the reference population. Two years of GH treatment increased and normalized the mean isometric knee extensor and flexor strengths. The concentric knee flexor and extensor strength at an angular velocity of {pi} rad/s increased, as did the concentric knee flexor strength at an angular velocity of {pi}/3 rad/s. The increase in muscle strength was more marked in younger patients and in patients with lower initial muscle strength than predicted. Quadriceps endurance decreased, whereas the effect of superimposing single twitches on isometric contraction and hand-grip strength was unaffected by the GH treatment. Two years of GH therapy in GH-deficient adults increased and normalized isokinetic and isometric muscle strength studied in proximal muscle groups. Hand-grip strength and the degree of lack of maximal motor unit activation on voluntary isometric knee extensor force did not change. The dynamic local muscle fatigue index decreased.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
J. Gibney, M.-L. Healy, and P. H. Sonksen
The Growth Hormone/Insulin-Like Growth Factor-I Axis in Exercise and Sport
Endocr. Rev., October 1, 2007; 28(6): 603 - 624.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
G Gotherstrom, B-A Bengtsson, I Bosaeus, G Johannsson, and J Svensson
Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency
Eur. J. Endocrinol., January 1, 2007; 156(1): 55 - 64.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
L. J. Woodhouse, A. Mukherjee, S. M. Shalet, and S. Ezzat
The Influence of Growth Hormone Status on Physical Impairments, Functional Limitations, and Health-Related Quality of Life in Adults
Endocr. Rev., May 1, 2006; 27(3): 287 - 317.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. E. Molitch, D. R. Clemmons, S. Malozowski, G. R. Merriam, S. M. Shalet, M. L. Vance, and for The Endocrine Society's Clinical Guidelines Su
Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1621 - 1634.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
J. Koranyi, I. Bosaeus, M. Alpsten, B.-A. Bengtsson, and G. Johannsson
Body composition during GH replacement in adults - methodological variations with respect to gender.
Eur. J. Endocrinol., April 1, 2006; 154(4): 545 - 553.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
J. Bollerslev, J. Hallen, K. J Fougner, A. P. Jorgensen, C. Kristo, H. Fagertun, O. Gudmundsen, P. Burman, and T. Schreiner
Low-dose GH improves exercise capacity in adults with GH deficiency: effects of a 22-month placebo-controlled, crossover trial
Eur. J. Endocrinol., September 1, 2005; 153(3): 379 - 387.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Berggren, C. Ehrnborg, T. Rosen, L. Ellegard, B.-A. Bengtsson, and K. Caidahl
Short-Term Administration of Supraphysiological Recombinant Human Growth Hormone (GH) Does Not Increase Maximum Endurance Exercise Capacity in Healthy, Active Young Men and Women with Normal GH-Insulin-Like Growth Factor I Axes
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3268 - 3273.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Kim, E. Barton, N. Muja, S. Yakar, P. Pennisi, and D. LeRoith
Intact Insulin and Insulin-Like Growth Factor-I Receptor Signaling Is Required for Growth Hormone Effects on Skeletal Muscle Growth and Function in Vivo
Endocrinology, April 1, 2005; 146(4): 1772 - 1779.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
K.-C. Leung, G. Johannsson, G. M. Leong, and K. K. Y. Ho
Estrogen Regulation of Growth Hormone Action
Endocr. Rev., October 1, 2004; 25(5): 693 - 721.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
S. M. Harman and M. R. Blackman
Hormones and Supplements: Do They Work?: Use of Growth Hormone for Prevention or Treatment of Effects of Aging
J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2004; 59(7): B652 - B658.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. G. Albert and A. D. Mooradian
Low-Dose Recombinant Human Growth Hormone as Adjuvant Therapy to Lifestyle Modifications in the Management of Obesity
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 695 - 701.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Svensson, K. Stibrant Sunnerhagen, and G. Johannsson
Five Years of Growth Hormone Replacement Therapy in Adults: Age- and Gender-Related Changes in Isometric and Isokinetic Muscle Strength
J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2061 - 2069.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Cittadini, L. Ines Comi, S. Longobardi, V. Rocco Petretta, C. Casaburi, L. Passamano, B. Merola, E. Durante-Mangoni, L. Sacca, and L. Politano
A preliminary randomized study of growth hormone administration in Becker and Duchenne muscular dystrophies
Eur. Heart J., April 1, 2003; 24(7): 664 - 672.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. T. Brill, A. L. Weltman, A. Gentili, J. T. Patrie, D. A. Fryburg, J. B. Hanks, R. J. Urban, and J. D. Veldhuis
Single and Combined Effects of Growth Hormone and Testosterone Administration on Measures of Body Composition, Physical Performance, Mood, Sexual Function, Bone Turnover, and Muscle Gene Expression in Healthy Older Men
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5649 - 5657.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
R. N. Butler, M. Fossel, S. M. Harman, C. B. Heward, S. J. Olshansky, T. T. Perls, D. J. Rothman, S. M. Rothman, H. R. Warner, M. D. West, et al.
Is There an Antiaging Medicine?
J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2002; 57(9): B333 - 338.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
D. M. Cook
Shouldn't Adults with Growth Hormone Deficiency Be Offered Growth Hormone Replacement Therapy?
Ann Intern Med, August 6, 2002; 137(3): 197 - 201.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Johannsson, P. Burman, L. Wiren, B. E. Engstrom, A. G. Nilsson, M. Ottosson, B. Jonsson, B.-A. Bengtsson, and F. A. Karlsson
Low Dose Dehydroepiandrosterone Affects Behavior in Hypopituitary Androgen-Deficient Women: A Placebo-Controlled Trial
J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2046 - 2052.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. H. W. Lange, J. L. Andersen, N. Beyer, F. Isaksson, B. Larsson, M. H. Rasmussen, A. Juul, J. Bulow, and M. Kjar
GH Administration Changes Myosin Heavy Chain Isoforms in Skeletal Muscle But Does Not Augment Muscle Strength or Hypertrophy, Either Alone or Combined with Resistance Exercise Training in Healthy Elderly Men
J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 513 - 523.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Gotherstrom, J. Svensson, J. Koranyi, M. Alpsten, I. Bosaus, B.-A. Bengtsson, and G. Johannsson
A Prospective Study of 5 Years of GH Replacement Therapy in GH-Deficient Adults: Sustained Effects on Body Composition, Bone Mass, and Metabolic Indices
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4657 - 4665.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Koranyi, J. Svensson, G. Gotherstrom, K. S. Sunnerhagen, B.-A. Bengtsson, and G. Johannsson
Baseline Characteristics and the Effects of Five Years of GH Replacement Therapy in Adults with GH Deficiency of Childhood or Adulthood Onset: A Comparative, Prospective Study
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4693 - 4699.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Hulthen, B.-A. Bengtsson, K. S. Sunnerhagen, L. Hallberg, G. Grimby, and G. Johannsson
GH Is Needed for the Maturation of Muscle Mass and Strength in Adolescents
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4765 - 4770.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
V. Y. Hayes, R. J. Urban, J. Jiang, T. J. Marcell, K. Helgeson, and N. Mauras
Recombinant Human Growth Hormone and Recombinant Human Insulin-Like Growth Factor I Diminish the Catabolic Effects of Hypogonadism in Man: Metabolic and Molecular Effects
J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2211 - 2219.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
Measures of Submaximal Aerobic Performance Evaluate and Predict Functional Response to Growth Hormone (GH) Treatment in GH-Deficient Adults
J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4570 - 4577.
[Abstract] [Full Text]


Home page
J. Appl. Physiol.Home page
W. J. Kraemer, K. Hakkinen, R. U. Newton, B. C. Nindl, J. S. Volek, M. McCormick, L. A. Gotshalk, S. E. Gordon, S. J. Fleck, W. W. Campbell, et al.
Effects of heavy-resistance training on hormonal response patterns in younger vs. older men
J Appl Physiol, September 1, 1999; 87(3): 982 - 992.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. J. Pritzlaff, L. Wideman, J. Y. Weltman, R. D. Abbott, M. E. Gutgesell, M. L. Hartman, J. D. Veldhuis, and A. Weltman
Impact of acute exercise intensity on pulsatile growth hormone release in men
J Appl Physiol, August 1, 1999; 87(2): 498 - 504.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. J. H. Janssen, J. Doornbos, and F. Roelfsema
Changes in Muscle Volume, Strength, and Bioenergetics during Recombinant Human Growth Hormone (GH) Therapy in Adults with GH Deficiency
J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 279 - 284.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Leger, C. Garel, A. Fjellestad-Paulsen, M. Hassan, and P. Czernichow
Human Growth Hormone Treatment of Short-Stature Children Born Small for Gestational Age: Effect on Muscle and Adipose Tissue Mass during a 3-Year Treatment Period and after 1 Year's Withdrawal
J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3512 - 3516.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Sartorio
Different Impairment of Muscle Strength in Adults with Childhood-Onset and Acquired GH Deficiency
J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 712 - 712.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society